United States News Todas as matérias

Jollibee Foods Corp. shares saw their largest single-day rally in 18 years on Tuesday after the Philippine fast-food giant announced a transformative plan to spin off its international business and list it on a U.S. stock exchange.

The move is designed to decouple the company’s high-growth global brands from its stable, cash-generative domestic operations, providing investors with "targeted exposure" to two distinct equity stories.

Advanced Micro Devices (NASDAQ:AMD) introduced a sweeping new portfolio of x86 processors at CES 2026, targeting the burgeoning "physical AI" market.

The new Ryzen AI Embedded P100 and X100 series are designed to bring high-performance, low-latency intelligence to automotive cockpits, industrial robotics, and autonomous systems, moving complex decision-making from the cloud to the device itself.

Moderna (NASDAQ:MRNA) officially moved to challenge the multi-billion-dollar seasonal influenza market today, submitting marketing authorization applications for its investigational vaccine, mRNA-1010, to regulators in the U.S., Europe, Canada, and Australia.

UMH Properties (NYSE:UMH) reported a transformative 2025 in its preliminary year-end update, fueled by a record expansion of its rental portfolio and a comprehensive refinancing of its debt stack.

Zenas BioPharma (NASDAQ:ZBIO), a clinical-stage global biopharmaceutical company focused on developing transformative immunology-based therapies for autoimmune diseases, today announced positive topline results from the Phase 3 INDIGO registrational trial evaluating obexelimab in patients with Immunoglobulin G4-Related Disease (IgG4-RD).

Neumora Therapeutics (NASDAQ:NMRA), a clinical-stage biopharmaceutical company focused on developing novel therapies for neuropsychiatric disorders and neurodegenerative diseases, today reported positive topline results from a Phase 1b signal-seeking study evaluating NMRA-511 as a potential treatment for agitation in patients with Alzheimer's disease.

RedHill Biopharma (NASDAQ:RDHL) is positioning its proprietary oral drug, RHB-102 (Bekinda), as a critical solution to the "discontinuation crisis" facing the blockbuster weight-loss drug market.

Gyre Therapeutics (NASDAQ:GYRE) is moving toward a landmark commercial entry in China after securing alignment with the Center for Drug Evaluation (CDE) on a conditional approval pathway for its lead anti-fibrotic candidate, Hydronidone (F351).

GH Research (NASDAQ:GHRS) shares surged in early trading Monday after the U.S. Food and Drug Administration lifted a long-standing clinical hold on its Investigational New Drug (IND) application for GH001.

Mobileye Global (NASDAQ:MBLY) shares jumped more than 7% in premarket trading Monday after the company announced a massive production win with a "top-ten" U.S. automaker.

Lucid Group (NASDAQ:LCID) reported a massive surge in manufacturing activity for 2025, successfully doubling its annual production as it ramps up deliveries of its new Gravity SUV.

The California-based luxury EV maker announced Monday that it produced 18,378 vehicles for the full year, a 104% increase over 2024, narrowly beating analyst estimates of approximately 17,910 units.

Parsons Corporation (NYSE:PSN) announced on Monday that it has been awarded a ten-year, $392 million single-award contract by an undisclosed federal customer.

The win represents "new work" for the Chantilly-based defense technology provider, further solidifying its position in the rapidly expanding market for mobile identity management and biometric security.

CGI (NYSE:GIB) has finalized the acquisition of Comarch Polska SA, a move that significantly expands the Canadian IT firm’s footprint in one of Europe’s fastest-growing digital economies.

Cango (NYSE:CANG) signaled a strong finish to 2025, reporting on Monday that its monthly Bitcoin production rose to 569 BTC in December.

Jacobs Solutions (NYSE:J) reached an agreement on Monday to acquire the remaining stake in PA Consulting for an upfront consideration of approximately £1.216 billion ($1.6 billion).

Shares of major US oil companies climbed sharply in premarket trading on Monday after President Donald Trump announced over the weekend that US forces had captured Venezuelan President Nicolás Maduro and his wife, stating that the United States intends to "run" the country temporarily while tapping into its vast crude reserves.

Kodiak (NASDAQ:KDK) and Bosch, the world’s largest automotive supplier, have entered into a strategic agreement to co-develop a production-grade, redundant autonomous trucking platform.

The collaboration is a major step toward moving self-driving technology from the pilot phase into large-scale commercial manufacturing.

Niu Technologies (NASDAQ:NIU), a leading provider of smart urban mobility solutions, today announced its sales volume results for the fourth quarter and full year 2025.

In the fourth quarter of 2025, the company sold a total of 178,702 units, comprising electric scooters, motorcycles, e-bicycles, and kick-scooters.

Taiwan Semiconductor Manufacturing Co. (NYSE:TSM) shares surged by their most since April on Monday, as the world’s largest contract chipmaker entered the new year riding a wave of relentless optimism over artificial intelligence demand.

Argenx SE (NASDAQ:ARGX) announced a significant leadership transition on Monday, appointing Chief Operating Officer Karen Massey as its new Chief Executive Officer and Executive Director, effective immediately.

HUTCHMED (NASDAQ:HCM) announced today that it has initiated the Phase III stage of its ongoing Phase II/III trial evaluating the combination of surufatinib, camrelizumab, nab-paclitaxel, and gemcitabine (S+C+AG) as a first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma (PDAC) in China.

Hawaiian Airlines (NYSE:ALK), now a unit of Alaska Air Group, announced a capital commitment of more than $600 million over the next five years to upgrade its airport infrastructure, technology platforms, and fleet interiors.

The Australian dollar slipped as geopolitical risks lifted the US dollar and kept pressure on risk-sensitive currencies.

The Indian rupee slipped to a two-week low as Trump’s tariff warnings and global tensions boosted the US dollar.